Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy
21m
·
Coronavirus (COVID-19) Q&A
·
In this interview, JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, explore with Erin K. McCreary, PharmD, and Atheendar S. Venkataramani, MD, PhD, how a large regional health system used a weighted lottery and intensive outreach to provide high-risk individuals in disadvantaged communities more equitable access to scarce monoclonal antibodies for preventing COVID-19.
Related Content:
- Weighted Lottery to Equitably Allocate Scarce Supply of COVID-19 Monoclonal Antibody
- Moving Beyond Intent and Realizing Health Equity
The episode Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy from the podcast Coronavirus (COVID-19) Q&A has a duration of
21:45. It was first published
More episodes from Coronavirus (COVID-19) Q&A
Association of New-Onset Seizures With SARS-CoV-2 Vaccines
Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. Armand, MD.
Related Content:
- Association of New-Onset Seizures With SARS-CoV-2 Vaccines
Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy
Benjamin D. Sommers, MD, PhD, of Harvard University, speaks with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about differences in Medicaid enrollment as measured in surveys and administrative data. These differences have implications for estimating coverage now that the federal policy of continuous Medicaid eligibility during the COVID-19 pandemic has ended.
Related Content:
- Survey-Reported Coverage in 2019-2022 and Implications for Unwinding Medicaid Continuous Eligibility
February 2024 Medical News Summary
Rural Maternity Care Is in Crisis—Here’s What Could Help; Type and Severity of Immunodeficiency Affect Speed of SARS-CoV-2 Clearance, Study Finds
Related Content:
- More Than Half of US Rural Hospitals No Longer Offer Birthing Services—Here’s Why
- When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike
Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.
Related Content:
- Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic
The COVID-19 pandemic has caused major disruptions in ambulatory care. In this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses how access to care and preventive services changed for different racial and ethnic groups in the US from 2019 to 2022.
Related Content:
- Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity